Symptoms of Low Evening Primrose Oil: Causes and Treatment
Deficiency
Symptoms & causes
Evening primrose oil is a plant-derived GLA supplement — not an essential nutrient in its own right — so no deficiency syndrome exists, though it is one source of gamma-linolenic acid (GLA), an omega-6 derivative the body can usually produce from linoleic acid.
Evening primrose oil (EPO) is a supplement pressed from the seeds of the evening primrose plant, valued for its gamma-linolenic acid (GLA) content. Unlike true essential nutrients, EPO itself is not required by the body, and there is no recognized clinical deficiency state for it. While some people take EPO for eczema, cyclical breast pain, or diabetic neuropathy, the evidence is mixed, and the supplement carries specific drug interactions that are often overlooked in wellness content.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Symptoms of low Evening primrose oil (EPO) — oil from the seeds of Oenothera biennis; notable for high content of gamma-linolenic acid (GLA, ~8–10% of oil) and linoleic acid (~65–80%). GLA is an omega-6 fatty acid the body normally produces from linoleic acid via delta-6-desaturase. EPO is not an essential nutrient; it is a supplemental GLA source.
Everyday signs are on the left; the ones on the right mean it's time to check in with a clinician.
Everyday signs
Common symptoms
- None specific to low EPO intake; no deficiency phenotype exists.
Don't wait
See a doctor if
- Not applicable to deficiency. Supplement caution: EPO may lower seizure threshold in people with seizure disorders or on phenothiazine antipsychotics; may interact with anticoagulants.
Who is most likely to run low
Some people are more prone to falling short than others — including many people on a weight-loss journey who are simply eating less.
- No deficiency population. People with impaired delta-6-desaturase (diabetes, certain inflammatory conditions) may benefit from supplemental GLA more than healthy people. Women with cyclical mastalgia and people with inflammatory skin conditions are the most-studied populations.
What causes low Evening primrose oil (EPO) — oil from the seeds of Oenothera biennis; notable for high content of gamma-linolenic acid (GLA, ~8–10% of oil) and linoleic acid (~65–80%). GLA is an omega-6 fatty acid the body normally produces from linoleic acid via delta-6-desaturase. EPO is not an essential nutrient; it is a supplemental GLA source.
- Not applicable to deficiency. Some conditions (diabetes, eczema-prone skin, aging) are associated with impaired delta-6-desaturase activity, reducing endogenous GLA production — this is a metabolic insufficiency, not a dietary EPO deficiency.
How low levels are diagnosed
No diagnostic test for EPO deficiency. Plasma fatty acid profiles can assess GLA/AA status but are not routine clinical practice for EPO supplementation decisions.
How it's corrected
Most gaps close with food first, and supplementation when a clinician recommends it.
Not applicable for deficiency. Dietary GLA sources: evening primrose oil, borage oil (higher GLA at ~20–26%), black currant seed oil; oats contain small amounts. Supplement: EPO capsules, typically 500–1,000 mg/day providing ~45–90 mg GLA.
How to keep levels up
Not applicable.
When to see a clinician
For chronic eczema, persistent breast pain, or diabetic neuropathy — clinical diagnosis and management, not self-supplementation. Discuss with clinician if on anticoagulants or anticonvulsants before using EPO.
Evening Primrose Oil Is Not an Essential Nutrient: Separating GLA from Linoleic Acid
The marketing around evening primrose oil often creates the impression that you need it — that without it, something is missing. That framing is misleading. EPO is not an essential nutrient, and there is no deficiency syndrome associated with low intake.
To understand why, you have to look at the fatty acid hierarchy. Linoleic acid (LA) is the essential omega-6 fatty acid — your body cannot make it, so you must get it from food. LA is abundant in the modern diet: vegetable oils, nuts, seeds, and virtually any processed food containing soybean or sunflower oil. Once consumed, your body converts LA into gamma-linolenic acid (GLA) using an enzyme called delta-6-desaturase.
Evening primrose oil provides pre-formed GLA, effectively bypassing that enzymatic step. This is useful in certain metabolic conditions where the enzyme isn't working efficiently, but it does not make EPO itself essential. If you eat adequate linoleic acid — which nearly everyone on a standard diet does — your body has the raw material to produce GLA. The 'deficiency' framing in EPO marketing capitalizes on confusion between an essential fatty acid and a downstream metabolite.
- Linoleic acid (LA): the essential omega-6 you must get from diet; abundant in vegetable oils, nuts, and seeds
- Gamma-linolenic acid (GLA): produced from LA in the body via delta-6-desaturase; not essential if enzyme function is normal
- Evening primrose oil: a supplemental source of pre-formed GLA, typically containing 8–10% GLA by weight
Bottom line
The essential omega-6 is linoleic acid, not GLA and not evening primrose oil; EPO supplements are a shortcut around the desaturase step, useful in some metabolic conditions — but not treating a deficiency.
What EPO Is Actually Used For: Eczema, PMS, and Breast Pain
Evening primrose oil gained popularity in the 1980s and 1990s primarily for eczema and women's health conditions. The evidence picture today is more nuanced than most supplement websites acknowledge.
For atopic dermatitis (eczema), early trials showed promise, and EPO became a go-to recommendation in alternative medicine circles. However, a 2013 Cochrane systematic review examined the pooled evidence and concluded there was insufficient evidence to recommend evening primrose oil or borage oil for eczema. Many of the positive trials were small, short, and predated current methodological standards. This doesn't mean EPO definitely doesn't work for eczema — it means the quality of evidence isn't strong enough to support a confident recommendation.
The strongest evidence for EPO is in cyclical mastalgia — breast pain that follows the menstrual cycle. Several randomized controlled trials have found that 3 to 4 grams of EPO daily for three to six months can reduce breast tenderness and pain. The effect is modest and requires consistent use over months, but the signal is more consistent here than in other applications. For PMS mood symptoms and cramping, the evidence is inconsistent, with some trials showing benefit and others showing none.
In diabetic peripheral neuropathy, GLA supplementation has some RCT support for improving nerve conduction velocity and reducing pain scores. The proposed mechanism involves GLA's conversion to dihomo-gamma-linolenic acid (DGLA) and subsequently to anti-inflammatory prostaglandin E1, which may support nerve function and reduce inflammation.
- Cyclical mastalgia: best-supported use; 3–4 g/day for 3–6 months shows modest pain reduction in multiple RCTs
- Eczema/atopic dermatitis: older positive trials, but 2013 Cochrane review found insufficient evidence to recommend
- PMS mood symptoms: inconsistent evidence; some trials positive, others show no benefit over placebo
- Diabetic neuropathy: some RCT support for improved nerve conduction and pain reduction with GLA supplementation
Bottom line
The strongest case for EPO is cyclical breast pain (mastalgia), where the evidence is more consistent than for eczema or PMS mood symptoms; but even here the effect is modest and requires months of use.
Delta-6-Desaturase and GLA in Metabolic Conditions: When EPO Might Actually Help
The most biologically coherent rationale for evening primrose oil supplementation has nothing to do with dietary deficiency. It has to do with enzyme function. Delta-6-desaturase — the enzyme that converts linoleic acid into GLA — is known to be less active in certain metabolic conditions, including diabetes, obesity, and chronic inflammatory states.
In these conditions, a person may consume adequate linoleic acid but still produce less GLA than a healthy person would. This creates a relative insufficiency of GLA — not a dietary deficiency of evening primrose oil, but a metabolic bottleneck. Supplementing with pre-formed GLA from EPO or borage oil bypasses that bottleneck, theoretically restoring downstream production of DGLA and anti-inflammatory prostaglandin E1.
This mechanism is particularly relevant to the population using GLP-1 receptor agonists for weight management. Many GLP-1 users have underlying insulin resistance or type 2 diabetes — conditions associated with impaired delta-6-desaturase activity. However, it's important to note that while the biological rationale is sound, direct clinical trial evidence testing EPO specifically in GLP-1 users or in obesity-related inflammation is limited. The theoretical basis is stronger than the clinical evidence base at this point.
- Delta-6-desaturase converts dietary linoleic acid into GLA; this enzyme's activity declines with insulin resistance, diabetes, and aging
- Reduced enzyme activity means less endogenous GLA production even with adequate LA intake — a metabolic insufficiency, not a dietary deficiency
- GLA → DGLA → PGE1 pathway is the proposed anti-inflammatory mechanism; PGE1 has vasodilatory and anti-inflammatory properties
- Borage oil provides a higher-concentration GLA source (20–26%) compared to EPO (8–10%) if GLA supplementation is clinically indicated
Bottom line
The metabolic condition most relevant to the GLP-1 user population — insulin resistance and obesity — is associated with impaired delta-6-desaturase activity, making EPO a more biologically plausible intervention here than in healthy people; but clinical trial evidence in this specific population is limited.
EPO and GLP-1 Therapy: Reduced Intake, Omega-6 Balance, and Drug Interactions
GLP-1 receptor agonists like semaglutide and tirzepatide reduce appetite and food intake, which means total fat consumption often drops. Could this create a GLA insufficiency? The short answer is no — linoleic acid is so abundant in the food supply that frank LA deficiency is virtually impossible even on a reduced-calorie diet. A single tablespoon of soybean oil provides roughly 7 grams of linoleic acid, far exceeding daily needs.
Evening primrose oil has no established role in weight management itself. It is not a weight-loss supplement, and no credible evidence supports using it for that purpose. For GLP-1 users who also have diabetic neuropathy, EPO's potential neuropathic pain application may be relevant — but this requires clinical evaluation and diagnosis, not self-supplementation based on internet research.
A more pressing concern for GLP-1 users is drug interactions. Many people on GLP-1 therapy are polypharmacy patients — they may also be taking antihypertensives, statins, anticoagulants, or anticonvulsants. Evening primrose oil has two clinically relevant interactions that are frequently missing from wellness content: it may lower the seizure threshold, which is concerning for people with epilepsy or those taking phenothiazine antipsychotics, and it may have mild anticoagulant effects, which matters for anyone on warfarin, direct oral anticoagulants, or antiplatelet therapy. These interactions are listed in clinical references but are routinely absent from supplement marketing.
- Linoleic acid is abundant in vegetable oils, nuts, and seeds — reduced food intake on GLP-1s will not create LA or GLA deficiency
- EPO is not a weight-loss supplement; no evidence supports its use for weight management
- Seizure threshold: EPO may lower it — relevant for people with epilepsy or on phenothiazine antipsychotics
- Anticoagulant interaction: EPO may have mild blood-thinning effects — discuss with clinician if on warfarin, DOACs, or antiplatelet drugs
- Polypharmacy GLP-1 patients should review all supplements with their prescribing clinician before adding EPO
Bottom line
EPO has no established role in GLP-1-related weight management; its potential neuropathy application may be relevant to the diabetic subset but requires clinical evaluation, not supplement self-prescription.
Choosing an EPO Supplement: GLA Content, Dosing, and Quality Markers
If you and your clinician decide that GLA supplementation is appropriate, the supplement you choose matters. Not all evening primrose oil products are equivalent, and the key number on the label isn't the total oil weight — it's the GLA content per capsule.
Standard evening primrose oil contains approximately 8–10% GLA by weight. A 1,000 mg EPO capsule therefore provides roughly 80–100 mg of GLA. Therapeutic doses used in clinical trials for cyclical mastalgia have typically been 3–4 grams of EPO per day, delivering approximately 240–400 mg of GLA. For eczema trials, doses have ranged from 2–6 grams daily. This means multiple capsules per day, taken consistently for months.
Borage oil is a higher-concentration alternative, containing roughly 20–26% GLA — more than double the GLA per gram compared to EPO. This means fewer capsules to achieve the same GLA dose. However, borage oil carries a different safety concern: some unregulated borage oil products may contain pyrrolizidine alkaloids, which are hepatotoxic. Products certified free of pyrrolizidine alkaloids are available and should be preferred if choosing borage oil.
Quality markers matter for any fatty acid oil supplement. Polyunsaturated oils like EPO are susceptible to oxidation and rancidity. Look for products that are third-party tested, packaged in dark glass bottles or opaque capsules to protect from light, and ideally include vitamin E as an antioxidant preservative. Compare cost per milligram of GLA rather than cost per capsule — a cheaper product with lower GLA content may actually be more expensive per effective dose.
- EPO GLA content: approximately 8–10% of total oil weight; a 1,000 mg capsule yields ~80–100 mg GLA
- Borage oil GLA content: approximately 20–26%; more efficient per capsule but verify pyrrolizidine alkaloid-free certification
- Therapeutic dosing: 3–4 g EPO/day for mastalgia (240–400 mg GLA); 2–6 g/day studied for eczema
- Quality indicators: third-party tested, protected from light and heat, vitamin E as antioxidant, clear GLA-per-capsule labeling
- Cost comparison: calculate cost per 100 mg GLA, not cost per capsule, to compare products accurately
Bottom line
If GLA supplementation is clinically indicated, the dose that matters is the GLA content, not the total EPO oil volume — check the label for GLA mg per capsule, not just total oil weight.
What most pages leave out
Most competitor content lists EPO as beneficial for eczema, PMS, and menopause without adequately disclosing that a Cochrane review found insufficient evidence for eczema, and that most positive eczema trials predate current evidence standards. The seizure-threshold concern is routinely absent from wellness content even though it is listed in clinical references.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
There are none. Evening primrose oil is not an essential nutrient, and no recognized clinical deficiency syndrome exists for it. The body produces its own GLA from dietary linoleic acid, which is abundant in most diets.
The best-supported use is cyclical breast pain (mastalgia), where 3–4 grams daily for several months has shown modest pain reduction in clinical trials. Evidence for eczema and PMS mood symptoms is weaker and inconsistent.
Standard evening primrose oil contains approximately 8–10% GLA by weight, so a 1,000 mg capsule provides roughly 80–100 mg of GLA. Borage oil is a higher-concentration alternative at roughly 20–26% GLA.
Older trials were positive, but a 2013 Cochrane systematic review found insufficient current evidence to recommend evening primrose oil or borage oil for eczema. The quality of evidence does not support a confident recommendation.
Yes. EPO may lower the seizure threshold, which is relevant for people with epilepsy or those taking phenothiazine antipsychotics. It may also have mild anticoagulant effects — discuss with your clinician if you take blood thinners.
No. There is no established evidence that evening primrose oil supports weight loss, and it should not be used as a weight-management intervention.
EPO is generally well-tolerated at typical doses. The main safety concerns are the potential to lower seizure threshold and mild anticoagulant effects. Borage oil, an alternative GLA source, may contain hepatotoxic pyrrolizidine alkaloids in some unregulated products.
There is no established benefit for EPO in the GLP-1 weight-loss context. If you have diabetic neuropathy or cyclical breast pain, discuss with your clinician. Drug interactions with anticoagulants may be relevant for polypharmacy patients.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
Symptoms of Low Coconut Oil: Causes and Treatment
Coconut oil is a dietary fat, not an essential nutrient — no deficiency syndrome exists. Learn why major health authorities recommend limiting its saturated fat content.
Read moreSymptoms of Low Black Currant Seed Oil: Causes and Treatment
Black currant seed oil is not an essential nutrient, and no recognized deficiency exists. Learn why GLA is synthesized by the body and what the oil is actually used for.
Read moreSymptoms of Low Cod Liver Oil: Causes and Treatment
There is no cod liver oil deficiency syndrome. Learn about the unique risks of vitamin A toxicity, how it differs from fish oil, and safe dosing practices.
Read moreSymptoms of Low Krill Oil: Causes, Treatment, and the Evidence
Krill oil is not a nutrient — no deficiency syndrome exists. It is an EPA/DHA source in phospholipid form with astaxanthin. Learn the evidence, cost, and GLP-1 context.
Read moreSymptoms of Low Borage Oil: Causes and Treatment
Borage oil is not an essential nutrient and no deficiency syndrome exists. Learn about its GLA content, eczema and RA evidence, and the critical pyrrolizidine alkaloid safety concern.
Read moreSymptoms of Low CBD Oil (Cannabidiol): Causes & Treatment
CBD is not a nutrient and no deficiency syndrome exists. Learn the truth about 'endocannabinoid deficiency,' CBD's real drug interaction risks, and what the evidence actually shows.
Read moreOn a GLP-1, or thinking about one?
Nutrient gaps are more common on a GLP-1 because you eat less — care that includes real clinical oversight helps you do it safely.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.